Background Image
Table of Contents Table of Contents
Previous Page  50 / 68 Next Page
Information
Show Menu
Previous Page 50 / 68 Next Page
Page Background

CARDIOVASCULAR JOURNAL OF AFRICA • Volume 26, No 3, May/June 2015

148

AFRICA

South African hospital the first in the Middle East, Africa, central

Asia and Turkey to implant the world’s smallest, minimally

invasive cardiac pacemaker

Groote Schuur Hospital in Cape Town

is the first hospital in the Middle East,

Africa, central Asia and Turkey to implant

the world’s smallest pacemaker: the

Medtronic Micra™ transcatheter pacing

system (TPS). The device was implanted

recently as part of the Medtronic global

pivotal clinical trial.

One-tenth the size of a conventional

pacemaker and comparable in size to a

large vitamin, the Micra TPS pacemaker

is delivered directly into the heart through

a catheter inserted into the femoral

vein. Once positioned, the pacemaker

is securely attached to the heart wall

and can be repositioned if needed. The

miniature device does not require the use

of wires, known as ‘leads’, to connect to

the heart. Attached to the heart via small

tines, the pacemaker delivers electrical

impulses that pace the heart through an

electrode at the end of the device.

‘This miniaturised technology is

designed to provide patients with

the advanced pacing technology

of traditional pacemakers via a

minimally invasive approach’, said Dr

Ashley Chin, consultant cardiologist/

electrophysiologist at Groote Schuur

Hospital and the University of Cape

Town, who implanted this first Micra

TPS. ‘We are proud that Groote Schuur

Hospital was selected among an elite

group of institutions to take part in this

global clinical trial. If positive, the results

of the trial could potentially benefit the

more than one million people globally

who receive pacemakers each year.’

In contrast to current pacemaker

implant procedures, the Micra TPS

implant does not require a surgical

incision in the chest and the creation of a

‘pocket’ under the skin. This eliminates a

potential source of complications, and any

visible sign of the device. The Medtronic

Micra TPS is an investigational device

worldwide.

For more information, contact

Michelle Burt on tel: 087 997 0120, cell:

083 295 1924 or e-mail: michelleb@

magna-carta.co.za

.